Compare · PRVA vs VSEE
PRVA vs VSEE
Side-by-side comparison of Privia Health Group Inc. (PRVA) and VSee Health Inc. (VSEE): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both PRVA and VSEE operate in Medical/Nursing Services (Health Care), so they compete in similar markets.
- PRVA is the larger of the two at $2.89B, about 1033.7x VSEE ($2.8M).
- Over the past year, PRVA is down 11.8% and VSEE is down 89.4% - PRVA leads by 77.7 points.
- VSEE has been more active in the news (3 items in the past 4 weeks vs 2 for PRVA).
- PRVA has more recent analyst coverage (25 ratings vs 1 for VSEE).
- Company
- Privia Health Group Inc.
- VSee Health Inc.
- Price
- $22.53-0.40%
- $0.05-40.65%
- Market cap
- $2.89B
- $2.8M
- 1M return
- +12.23%
- +0.00%
- 1Y return
- -11.75%
- -89.44%
- Industry
- Medical/Nursing Services
- Medical/Nursing Services
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2021
- 2021
- News (4w)
- 2
- 3
- Recent ratings
- 25
- 1
Privia Health Group Inc.
Privia Health Group, Inc. operates as a physician practice management and population health technology company in the United States. The company comprises regional medical groups, accountable care organizations, and specialty verticals. It offers technology and population health tools to enhance independent providers' workflows; management service organization that enables providers to reduce administrative work focus on their patients; single-TIN medical group that facilitates payer negotiation, clinical integration and alignment of financial incentives; physician-led accountable care organization, which engages patients, reduces inappropriate utilization, and enhances coordination and patient quality metrics to drive value-based care and transform the healthcare delivery system; and network for purchasers and payers. The company was founded in 2007 and is headquartered in Arlington, Virginia. Privia Health Group, Inc. operates as a subsidiary of Brighton Health Group Holdings, LLC.
Latest PRVA
- Privia Health to Report Third Quarter 2026 Results on Thursday, November 5
- Amendment: SEC Form SCHEDULE 13G/A filed by Privia Health Group Inc.
- Director Ernest Opella Finley was granted 6,350 shares (SEC Form 4)
- SEC Form 3 filed by new insider Ernest Opella Finley
- Privia Health Group Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits
- Privia Health Announces Appointment of Opella Ernest, M.D. to its Board of Directors
- SEC Form 10-Q filed by Privia Health Group Inc.
- Privia Health Group Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Privia Health Reports Strong Second Quarter and Year-to-Date 2026 Results
- EVP & Chief Financial Officer Mountcastle David sold $588,679 worth of shares (21,275 units at $27.67) as part of a pre-agreed trading plan, decreasing direct ownership by 11% to 164,853 units (SEC Form 4)
Latest VSEE
- SEC Form S-1 filed by VSee Health Inc.
- VSee Health Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Unregistered Sales of Equity Securities, Financial Statements and Exhibits
- VSee Health Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits
- VSee Health Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits
- VSee Health Inc. filed SEC Form 8-K: Leadership Update
- VSee Health Poised for Growth
- VSee Health Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
- Amendment: SEC Form SCHEDULE 13G/A filed by VSee Health Inc.
- VSee Health Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
- VSee Health Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Unregistered Sales of Equity Securities, Financial Statements and Exhibits